CLINICAL_TRIALS
trial_result
· 2016-06-28
Clinical Trial Update: Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 2]
Summary
A Phase 2 study evaluating the efficacy and safety of etoposide in patients with relapsed non-Hodgkin lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED